Budget Amount *help |
¥18,850,000 (Direct Cost: ¥14,500,000、Indirect Cost: ¥4,350,000)
Fiscal Year 2010: ¥6,110,000 (Direct Cost: ¥4,700,000、Indirect Cost: ¥1,410,000)
Fiscal Year 2009: ¥6,110,000 (Direct Cost: ¥4,700,000、Indirect Cost: ¥1,410,000)
Fiscal Year 2008: ¥6,630,000 (Direct Cost: ¥5,100,000、Indirect Cost: ¥1,530,000)
|
Research Abstract |
It has been expected that the personalized medicine is essential for the near future treatment strategy of colorectal cancer with clinical application of the OMICS technology such as functional genomics, proteomics and metabolomics. In this study, several biological markers for the colorectal cancer were successfully isolated in each OMICS level. They are promising and paly important roles for the diagnosis or detection of cancer, the prediction of recurrence or treatment responsiveness that had been difficult with the conventional pathological diagnosis.
|